Sfoglia per Autore
Long-term efficacy in patients with relapsed/refractory diffuse large B-cell lymphoma achieving a complete response with pixantrone
2023-01-01 Cencini, E.; Rocco, M.; Ghio, F.; Simonetti, F.; Cuccaro, A.; De Marco, F.; Consoli, C.; Bocchia, M.; Fabbri, A.
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study
2023-01-01 Cencini, Emanuele; Sicuranza, Anna; Fabbri, Alberto; Marzano, Cristina; Pacelli, Paola; Caroni, Federico; Raspadori, Donatella; Bocchia, Monica
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma
2023-01-01 Perrone, G.; Rigacci, L.; Urru, S.; Kovalchuk, S.; Brugia, M.; Fabbri, A.; Iovino, L.; Puccini, B.; Cencini, E.; Orciuolo, E.; Birtolo, S.; Melosi, A.; Santini, S.; Landini, I.; Roviello, G.; Santi, R.; Macciotta, A.; Ricceri, F.; Bosi, A.; Bocchia, M.; Petrini, M.; Mini, E.; Nobili, S.
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications
2023-01-01 Cencini, E.; Sicuranza, A.; Ciofini, S.; Fabbri, A.; Bocchia, M.; Gozzetti, A.
Characteristics of Primary Cutaneous Lymphoma in Italy: A Tertiary Care, Single-Center Study
2023-01-01 D'Onghia, M.; Cartocci, A.; Calabrese, L.; Maio, D.; Sirchio, A.; Erasti, M.; Tognetti, L.; Rubegni, P.; Bocchia, M.; Cencini, E.; Fabbri, A.; Cinotti, E.
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network)
2023-01-01 Cencini, E.; Romano, I.; Ghio, F.; Camerini, C.; Bertaggia, I.; Giachetti, R.; Mannelli, L.; Pirrotta, M. T.; Navei, G. L.; Ciceri, M.; Cervetti, G.; Sant'Antonio, E.; Simonetti, F.; Birtolo, S.; Puccini, B.; Bocchia, M.; Fabbri, A.
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi
2023-01-01 Cencini, E.; Tucci, A.; Puccini, B.; Cavallo, F.; Luminari, S.; Usai, S. V.; Fabbri, A.; Pennese, E.; Marino, D.; Zilioli, V. R.; Balzarotti, M.; Petrucci, L.; Tafuri, A.; Arcari, A.; Botto, B.; Zanni, M.; Hohaus, S.; Sartori, R.; Merli, M.; Gini, G.; Al Essa, W.; Musurca, G.; Tani, M.; Nassi, L.; Daffini, R.; Mammi, C.; Marcheselli, L.; Bocchia, M.; Spina, M.; Merli, F.
Two secondary localisation of non-Hodgkin's lymphomas in the upper gastrointestinal tract
2022-01-01 Calomino, Natale; Fusario, Daniele; Cencini, Emanuele; Lazzi, Stefano
Pixantrone in patients with relapsed/refractory diffuse large B-cell lymphoma: A real-life, retrospective, multicenter trial on behalf of the “RTL” (Regional Tuscan Lymphoma network)
2022-01-01 Cencini, E; Mecacci, B.; Rocco, M.; Innocenti, F.; Ghio, F.; Puccini, B.; Della Seta, R.; Simonetti, F.; Mannelli, L.; Cuccaro, A.; Bocchia, M.; Fabbri, A.
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study)
2022-01-01 Sicuranza, A.; Ferrigno, I.; Abruzzese, E.; Iurlo, A.; Galimberti, S.; Gozzini, A.; Luciano, L.; Stagno, F.; Russo Rossi, A.; Sgherza, N.; Cattaneo, D.; Zuanelli Brambilla, C.; Marzano, C.; Fava, C.; Mulas, O.; Cencini, E.; Santoni, A.; Sammartano, V.; Gozzetti, A.; Puccetti, L.; Bocchia, M.
Tp53 disruptions: Is there a marker of poor prognosis in chronic lymphoproliferative disorders?
2021-01-01 Cencini, E.; Fabbri, A.; Raspadori, D.; Gozzetti, A.; Bocchia, M.
Ibrutinib in association with venetoclax for the treatment of mantle-cell lymphoma: a multicenter case series
2020-01-01 Fabbri, Alberto; Cencini, Emanuele; Congiu, Angela Giovanna; Miglino, Maurizio; Rigacci, Luigi; Bocchia, Monica
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications
2020-01-01 Granai, Massimo; Amato, Teresa; Napoli., Arianna Di; Santi., Raffaella; Vergoni., Federica; Stefano., Gioia Di; Mancini, Virginia; K., Sofya; Cencini, Emanuele; Carta, GIULIO ALBERTO; Aversa, Sara; M., Ziepert; Cevenini, Gabriele; Lazzi, Stefano; Leoncini, Lorenzo; Bellan, Cristiana
Coexistence of Serum Monoclonal Gammopathy of Uncertain Significance and Hodgkin Lymphoma
2020-01-01 Cencini, E.; Fabbri, A.; Santoni, A.; Mecacci, B.; Bocchia, M.
Prognostic impact of tumor-associated macrophages, lymphocyte-to-monocyte and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma
2020-01-01 Cencini, Emanuele; Fabbri, Alberto; Schiattone, Luana; Sicuranza, Anna; Mecacci, Bianca; Granai, Massimo; Mancini, Virginia; Lazzi, Stefano; Bocchia, Monica; Leoncini, Lorenzo
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications (Virchows Archiv, (2020), 477, 1, (143-150), 10.1007/s00428-019-02712-8)
2020-01-01 Granai, M.; Amato, T.; Di Napoli, A.; Santi, R.; Vergoni, F.; Di Stefano, G.; Mancini, V.; Kovalchuk, S.; Cencini, E.; Carta, A. G.; Aversa, S.; Ziepert, M.; Cevenini, G.; Lazzi, S.; Leoncini, L.; Bellan, C.
Is bendamustine plus rituximab a suitable option for rituximab-refractory duodenal-type follicular lymphoma?
2020-01-01 Cencini, E; Fabbri, A; Mecacci, B; Bocchia, M
How to manage early-stage follicular lymphoma
2020-01-01 Cencini, Emanuele; Fabbri, Alberto; Mecacci, Bianca; Bocchia, Monica
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients
2020-01-01 Gozzetti, Alessandro; Bacchiarri, Francesca; Sammartano, Vincenzo; Defina, Marzia; Sicuranza, Anna; Mecacci, Bianca; Zappone, Elisabetta; Cencini, Emanuele; Fabbri, Alberto; Raspadori, Donatella; Bocchia, Monica
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia
2020-01-01 Sammartano, Vincenzo; Santoni, Adele; Defina, Marzia; Ciofini, Sara; Cencini, Emanuele; Bocchia, Monica
Titolo | Data di pubblicazione | Autore(i) | File | Abstract |
---|---|---|---|---|
Long-term efficacy in patients with relapsed/refractory diffuse large B-cell lymphoma achieving a complete response with pixantrone | 1-gen-2023 | Cencini, E.; Rocco, M.; Ghio, F.; Simonetti, F.; Cuccaro, A.; De Marco, F.; Consoli, C.; Bocchia, M.; Fabbri, A. | - | |
The prognostic role of gene polymorphisms in patients with indolent non-Hodgkin lymphomas and mantle-cell lymphoma receiving bendamustine and rituximab: results of the 5-year follow-up study | 1-gen-2023 | Cencini, Emanuele; Sicuranza, Anna; Fabbri, Alberto; Marzano, Cristina; Pacelli, Paola; Caroni, Federico; Raspadori, Donatella; Bocchia, Monica | - | |
Exploratory Genome-Wide Association Analysis to Identify Pharmacogenetic Determinants of Response to R-CHOP in Diffuse Large B-Cell Lymphoma | 1-gen-2023 | Perrone, G.; Rigacci, L.; Urru, S.; Kovalchuk, S.; Brugia, M.; Fabbri, A.; Iovino, L.; Puccini, B.; Cencini, E.; Orciuolo, E.; Birtolo, S.; Melosi, A.; Santini, S.; Landini, I.; Roviello, G.; Santi, R.; Macciotta, A.; Ricceri, F.; Bosi, A.; Bocchia, M.; Petrini, M.; Mini, E.; Nobili, S. | - | |
Tumor-Associated Macrophages in Multiple Myeloma: Key Role in Disease Biology and Potential Therapeutic Implications | 1-gen-2023 | Cencini, E.; Sicuranza, A.; Ciofini, S.; Fabbri, A.; Bocchia, M.; Gozzetti, A. | - | |
Characteristics of Primary Cutaneous Lymphoma in Italy: A Tertiary Care, Single-Center Study | 1-gen-2023 | D'Onghia, M.; Cartocci, A.; Calabrese, L.; Maio, D.; Sirchio, A.; Erasti, M.; Tognetti, L.; Rubegni, P.; Bocchia, M.; Cencini, E.; Fabbri, A.; Cinotti, E. | - | |
Ibrutinib in relapsed/refractory patients with Waldenström macroglobulinemia: a real-life, retrospective study on behalf of the “RTL” (regional Tuscan lymphoma network) | 1-gen-2023 | Cencini, E.; Romano, I.; Ghio, F.; Camerini, C.; Bertaggia, I.; Giachetti, R.; Mannelli, L.; Pirrotta, M. T.; Navei, G. L.; Ciceri, M.; Cervetti, G.; Sant'Antonio, E.; Simonetti, F.; Birtolo, S.; Puccini, B.; Bocchia, M.; Fabbri, A. | - | |
The elderly prognostic index predicts early mortality in older patients with diffuse large B-cell lymphoma. An ad hoc analysis of the elderly project by the Fondazione Italiana Linfomi | 1-gen-2023 | Cencini, E.; Tucci, A.; Puccini, B.; Cavallo, F.; Luminari, S.; Usai, S. V.; Fabbri, A.; Pennese, E.; Marino, D.; Zilioli, V. R.; Balzarotti, M.; Petrucci, L.; Tafuri, A.; Arcari, A.; Botto, B.; Zanni, M.; Hohaus, S.; Sartori, R.; Merli, M.; Gini, G.; Al Essa, W.; Musurca, G.; Tani, M.; Nassi, L.; Daffini, R.; Mammi, C.; Marcheselli, L.; Bocchia, M.; Spina, M.; Merli, F. | - | |
Two secondary localisation of non-Hodgkin's lymphomas in the upper gastrointestinal tract | 1-gen-2022 | Calomino, Natale; Fusario, Daniele; Cencini, Emanuele; Lazzi, Stefano | - | |
Pixantrone in patients with relapsed/refractory diffuse large B-cell lymphoma: A real-life, retrospective, multicenter trial on behalf of the “RTL” (Regional Tuscan Lymphoma network) | 1-gen-2022 | Cencini, E; Mecacci, B.; Rocco, M.; Innocenti, F.; Ghio, F.; Puccini, B.; Della Seta, R.; Simonetti, F.; Mannelli, L.; Cuccaro, A.; Bocchia, M.; Fabbri, A. | - | |
Pro-Inflammatory and Pro-Oxidative Changes During Nilotinib Treatment in CML Patients: Results of a Prospective Multicenter Front-Line TKIs Study (KIARO Study) | 1-gen-2022 | Sicuranza, A.; Ferrigno, I.; Abruzzese, E.; Iurlo, A.; Galimberti, S.; Gozzini, A.; Luciano, L.; Stagno, F.; Russo Rossi, A.; Sgherza, N.; Cattaneo, D.; Zuanelli Brambilla, C.; Marzano, C.; Fava, C.; Mulas, O.; Cencini, E.; Santoni, A.; Sammartano, V.; Gozzetti, A.; Puccetti, L.; Bocchia, M. | - | |
Tp53 disruptions: Is there a marker of poor prognosis in chronic lymphoproliferative disorders? | 1-gen-2021 | Cencini, E.; Fabbri, A.; Raspadori, D.; Gozzetti, A.; Bocchia, M. | - | |
Ibrutinib in association with venetoclax for the treatment of mantle-cell lymphoma: a multicenter case series | 1-gen-2020 | Fabbri, Alberto; Cencini, Emanuele; Congiu, Angela Giovanna; Miglino, Maurizio; Rigacci, Luigi; Bocchia, Monica | - | |
IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications | 1-gen-2020 | Granai, Massimo; Amato, Teresa; Napoli., Arianna Di; Santi., Raffaella; Vergoni., Federica; Stefano., Gioia Di; Mancini, Virginia; K., Sofya; Cencini, Emanuele; Carta, GIULIO ALBERTO; Aversa, Sara; M., Ziepert; Cevenini, Gabriele; Lazzi, Stefano; Leoncini, Lorenzo; Bellan, Cristiana | - | |
Coexistence of Serum Monoclonal Gammopathy of Uncertain Significance and Hodgkin Lymphoma | 1-gen-2020 | Cencini, E.; Fabbri, A.; Santoni, A.; Mecacci, B.; Bocchia, M. | - | |
Prognostic impact of tumor-associated macrophages, lymphocyte-to-monocyte and neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma | 1-gen-2020 | Cencini, Emanuele; Fabbri, Alberto; Schiattone, Luana; Sicuranza, Anna; Mecacci, Bianca; Granai, Massimo; Mancini, Virginia; Lazzi, Stefano; Bocchia, Monica; Leoncini, Lorenzo | - | |
Correction to: IGHV mutational status of nodal marginal zone lymphoma by NGS reveals distinct pathogenic pathways with different prognostic implications (Virchows Archiv, (2020), 477, 1, (143-150), 10.1007/s00428-019-02712-8) | 1-gen-2020 | Granai, M.; Amato, T.; Di Napoli, A.; Santi, R.; Vergoni, F.; Di Stefano, G.; Mancini, V.; Kovalchuk, S.; Cencini, E.; Carta, A. G.; Aversa, S.; Ziepert, M.; Cevenini, G.; Lazzi, S.; Leoncini, L.; Bellan, C. | - | |
Is bendamustine plus rituximab a suitable option for rituximab-refractory duodenal-type follicular lymphoma? | 1-gen-2020 | Cencini, E; Fabbri, A; Mecacci, B; Bocchia, M | - | |
How to manage early-stage follicular lymphoma | 1-gen-2020 | Cencini, Emanuele; Fabbri, Alberto; Mecacci, Bianca; Bocchia, Monica | - | |
Long-Term Safety of Rapid Daratumumab Infusions in Multiple Myeloma Patients | 1-gen-2020 | Gozzetti, Alessandro; Bacchiarri, Francesca; Sammartano, Vincenzo; Defina, Marzia; Sicuranza, Anna; Mecacci, Bianca; Zappone, Elisabetta; Cencini, Emanuele; Fabbri, Alberto; Raspadori, Donatella; Bocchia, Monica | - | |
Efficacy and safety of eltrombopag during conception and first trimester of pregnancy in a case of refractory severe immune thrombocytopenia | 1-gen-2020 | Sammartano, Vincenzo; Santoni, Adele; Defina, Marzia; Ciofini, Sara; Cencini, Emanuele; Bocchia, Monica | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile